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Objective 
Up to 50% of patients with Amyotrophic Lateral Sclerosis (ALS) show mild to moderate 
cognitive–behavioural change alongside their progressive functional impairment. This study 
examines the relative impact of patients’ disease symptoms, behavioural change and current 
executive function and social cognition abilities on psychosocial outcomes in spouse 
caregivers of people with ALS.  
 
Methods 
Thirty–five spouse caregivers rated their own levels of depression and anxiety, subjective 
burden and marital satisfaction. Caregivers also rated their partner's everyday behaviour. The 
patients were assessed for disease severity and cognitive function, with composite scores 
derived for executive function and social cognition. 
 
Results 
Regression analyses revealed that caregiver burden was predicted by the severity of patients’ 
limb involvement and behavioural problems. Depression was predicted by patients’ limb 
involvement, while behavioural problems and patient age predicted caregiver anxiety. 
Current marital satisfaction was predicted by patient behavioural problems beyond the level 
of pre–illness marital satisfaction. 
 
Conclusions    
The study highlights the potential impact of ALS patients’ functional impairment and 
behavioural change on ALS caregivers’ psychosocial functioning. Clinical communication 
with ALS families should emphasise both physical and psychological challenges presented 
by the disease. 
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Introduction 
While less marked than observed in frontotemporal dementia (FTD), up to 50% of non–
demented patients with Amyotrophic Lateral Sclerosis (ALS) may show behavioural 
symptoms (1) including apathy, disinhibition and/or egocentrism (2–4). In addition, non–
demented people with ALS may also show impaired performance on standardised tasks of 
executive function (5) and social cognition (6–9). In informal family caregivers, mood and 
subjective burden is affected by the patients’ functional impairment (10–12) and the presence 
of behavioural change (13–15). However, the contribution of cognitive impairment, as 
assessed by standardised tests, is unclear. The current study sought to explore the relative 
impact of patient disease, objective cognitive function and behavioural change on four 
indicators of caregiver outcome: depression, anxiety, burden and marital satisfaction.  
 
Material and Methods 
Participants 
Spouse caregivers were recruited as part of a parallel study which explored cognitive and 
behavioural change in non–demented patients with ALS (for information about this study see 
Supplementary Appendix Table S1). Participants were recruited between January 2011 and 
May 2013 from five Motor Neurone Disease Care and Research Centres in the UK. The 
following exclusion criteria were applied for all participants: a diagnosis of a psychiatric 
condition; a formal diagnosis of dementia; a first language other than English. Patients were 
excluded from the parallel study on the basis of a formal diagnosis of another neurological 
condition or diabetes; aged > 75 years and evidence of respiratory insufficiency, as 
determined by the patients’ clinical team; a forced vital capacity (FVC) < 70% (where 
available) and a score > 10 on the Epworth Sleepiness Scale (16). In total, 46 caregivers were 
approached with approval of the patient with ALS. Nine declined, and one was excluded due 
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to dementia. One carer was excluded as they could not provide a report on their relationship 
prior to their spouse’s illness. Informed written consent was obtained from the remaining 35 
caregivers and their spouses. Ethics approval was obtained from the National Research Ethics 
South East London Research Ethics Committee 4 (11/H0807/1; dated 22/03/2011).  
 
Measures 
Caregiver outcome  
The Hospital Anxiety and Depression Scale (HADS) (17) was used to measure caregiver 
anxiety (HADS A) and depression (HADS D). The Zarit Burden Inventory (ZBI) (18) 
measured caregivers’ perceived burden associated with their partner’s illness and their 
caregiving role. Caregivers’ perceived marital satisfaction was measured using the Marital 
Intimacy Scale (MIS) (19), which assesses several dimensions of the marital relationship, 
such as affection, compatibility and autonomy. Caregivers completed this measure with 
respect to the time of the interview (MIS current) and a time approximately two years before 
the onset of their partner’s ALS (MIS pre–illness).  
 
ALS measures 
Physical symptom severity was assessed using the Revised Amyotrophic Lateral Sclerosis 
Scale (ALSFRS–R) (20). Patients’ mood was measured using the revised HADS (HADS-R), 
which removes two items that may be confounded with the physical impairment of ALS (21). 
Cognitive function was assessed on a range of neuropsychological tests of executive function 
and social cognition. Table 1 provides descriptions and references (22-27) for these tasks. To 
reduce the number of variables used in the analyses, composite scores were created as 
follows: test scores were standardised by subtracting the mean score of the control group 
from each participant’s score on an individual test and then dividing the difference by the 
corresponding standard deviation of the control group. The resulting standardised scores were 
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then summed according to theorized function and divided by the number of component tests 
contributing to the composite. When participants did not complete all measures in the 
composite, the measures that were completed were standardised and averaged as above. 
Where necessary, scores were reflected so that they shared the same direction; a higher score 
represented poorer performance. Internal consistency for these composites for the patient 
group (n=35) were satisfactory (Executive function composite α=.79; Social cognition 
composite α=.89).  Caregivers rated their partner’s current behaviour using the informant 
version of the Frontal Systems Behavioural Scale (FrSBe) (28) (apathy, disinhibition and 
everyday behavioural indications of executive dysfunction) and emotional lability using the 
Emotional Lability Questionnaire (ELQ) (29). 
 
Data Analysis 
Data were analysed using IBM SPSS for Windows version 21 (IBM SPSS Statistics Armonk, 
NY, USA). Demographic, clinical and cognitive characteristics were reported as percentages 
for categorical data and means for continuous variables. Categorical data were analysed using 
Chi–square tests. Outliers were identified and transformed by recoding the outlying value 
with a score one unit higher/lower than the next highest/lowest non–outlying score in the 
distribution. Pearson’s correlations and multiple regression analyses were used to examine 
the relationships between parameter and caregiver outcome variables. All tests were two–
tailed, and statistical significance was set at p < 0.05.  
 
Results 
 
ALS sample characteristics 
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Patients’ demographics and disease information are shown in Table 2. Limb onset disease 
was observed in 77.1% and bulbar onset in the remainder. Most patients (80%) were 
receiving treatment with riluzole. Table 3 shows patients’ mood scores, cognitive composite 
scores, mean group performance on individual cognitive tests and the percentage of patients 
whose performance was at or lower than the 5
th 
percentile of an age-, education-, gender-
matched control sample from a larger parallel study (see Supplementary Appendix Table S1). 
Table 3 also shows caregiver ratings of patient behavioural involvement and emotional 
lability.  The percentage of patients being endorsed by their caregivers as demonstrating 
clinically relevant behaviour (a T-score > 65 on the FrSBe domains) is also shown. Figure 1 
presents the proportion of patients by number of impaired scores on the cognitive tasks (as 
defined as a score at or lower than 5
th
 percentile of controls’ scores) and behaviour domains 
(as defined by T-Score >65). The number of patients meeting current cognitive impairment 
criteria (30) (impairments on two or more tests of executive function) was 3/35 (8.6%). By 
extension, the number of impairments on two or more domains of social cognition was 4/35 
(11.4%). The number of patients meeting criteria for impairment on two or more domains of 
the FrSBe was 8/33 (24.2%).  
 
Caregiver sample characteristics 
 
The mean age of the caregiver group was 57.7 years (SD = 10.5) and 71.4% were female. 
The mean duration of their marriage to the patient was 33.2 years (SD = 13). Table 4 shows 
levels of caregiver anxiety, depression, burden and marital satisfaction (current and pre–
illness). Pre–illness MIS ratings (M = 76.1, SD = 15.4) were significantly higher than current 
MIS ratings (M = 70.2, SD = 18.4), t(31) = 3.04, p = 0.005, d = 0.35. Current and pre–illness 
MIS scores were highly correlated (r = 0.81, p < 0.001). 
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Predictors of caregiver outcome 
 
Potential predictor variables were selected on the basis of past research (10–15) and the 
objectives of the study and comprised ALSFRS–R subscale scores; months since diagnosis; 
Executive and Social Cognition composite scores; FrSBe Total and subscale T–scores; ELQ 
total severity score; caregivers’ age; patients’ age, patients’ HADS-R scores and years of 
marriage. Variables which showed significant paired associations with the outcomes (p < 
0.05) were entered into forward selection multiple regressions (Table 5). The correlations 
between outcome measures are shown in the Supplementary Appendix S2.  
  
Caregiver depression: Significant correlates of caregiver HADS D were ALSFRS–R Limb (r 
= -0.48, p = 0.004, n = 35), FrSBe Apathy (r = 0.43, p = 0.01, n = 33) and FrSBe Total (r = 
0.37, p = 0.04, n = 33). Only ALSFRS–R Limb entered the final model (F(1,31) = 8.07, p = 
0.08)  explaining 18% of the variance, with greater functional impairment (lower ALSFRS–R 
limb scores) associated with higher caregiver depression (higher HADS D scores). 
 
Caregiver anxiety: Significant correlates of caregiver HADS A were FrSBe Total (r = 0.40, p 
= 0.02, n = 33), ELQ Total (r = 0.36, p = 0.03, n = 34), patients’ age (r = -0.4, p = 0.03, n = 
35) and ALSFRS–R Limb (r = -0.38, p = 0.03, n = 35). FrSBe Total and patients’ age 
remained in the model (F(1,30) = 5.4, p = 0.01), explaining 22% of anxiety variance. Greater 
carer anxiety (higher HADS A scores) was predicted by greater behavioural impairment 
(higher FrSBe Total scores) and younger patient age.  
 
Caregiver burden: Significant correlates of the ZBI score were ALSFRS–R Limb (r = -0.66, 
p = <0.001, n = 34), FrSBe Apathy (r = 0.63, p <0.001, n = 32), FrSBe Disinhibition (r = 
0.51, p = 0.003, n = 32), FrSBe Executive Dysfunction (r = 0.51, p = 0.003, n = 32), FrSBe 
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Total (r = 0.69, p <0.001, n = 32) and patients’ age (r = -0.35, p = 0.04,  n = 34). ALSFRS–R 
Limb and the FrSBe Total remained in the model (F(2,28) = 80.7, p <0.001) and explained 
84% of the variance in caregiver burden. Caregiver burden increased with worsening physical 
impairment (lower ALSFRS–R limb scores) and behavioural problems (higher FrSBe Total 
scores) in the person with ALS. 
 
Current caregiver marital satisfaction: Significant correlates of current MIS scores were 
FrSBe Apathy (r = -0.37, p = 0.04, n = 31), FrSBe Executive Dysfunction (r = -0.49, p = 
0.005, n = 31) and FrSBe Total (r = -0.54, p = 0.002, n = 31). Only FrSBe Total entered the 
model, R
2 
= 0.30, adjusted R
2 
= 0.27, F(1,29) = 12.12, p = 0.002, standardised β  = -0.54, 
t(29) = -3.48, p = 0.002. To control for the possible influence of pre–illness marital 
satisfaction FrSBe Total scores were then entered into a hierarchical regression analysis, 
controlling for pre–illness MIS scores. The model explained 78% of the variance in 
caregivers’ current marital satisfaction (F(2,27) = 52.7, p <0.001) with FrSBe Total scores 
remaining a significant independent predictor.    
 
Selection bias 
Caregivers were invited to the study on the condition that their partner with ALS took part in 
a larger study (see Supplementary Appendix Table S1) and consented to their spouse being 
approached. Data for the 9 spouses who declined invitation are not available; however, the 
demographic, disease and cognitive profiles of the 9 patients (n = 2 female) whose spouses 
declined participation are shown in Table S3 in the Supplementary Appendix.  
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Discussion  
 
Previous studies have highlighted the impact of disease factors (10–12) and behavioural 
change (13–15) on caregivers of ALS, but the contribution of objectively measured patient 
cognition function has not been established. The present results suggest that formal measures 
of executive function and social cognition do not independently predict any of the caregiver 
outcomes assessed. This is in contrast to previous studies of caregivers of patients with 
dementia (31), but similar to reports of caregivers of patients with Mild Cognitive 
Impairment (32). Together, such evidence suggests that for caregivers of non–demented 
patients (including ALS) the perceived severity of patients’ everyday behavioural impairment 
(as reflected in FrSBe ratings) have a greater effect on caregiver well–being than the 
objective level of cognitive impairment.  However, the profile of cognitive impairments in 
the current patient sample may have influenced the results obtained. While impairments in 
performance on some measures of executive function and social cognition were noted in 
some patients, only a small proportion of patients qualified for cognitive impairment 
according to Strong et al’s criteria. Thus, patients’ cognitive deficits might not have been 
severe enough to interfere with their everyday actives or create burden for their caregiver. 
With progression, and worsening of cognitive function in some patients, caregivers may 
become more aware of and affected by cognitive impairment and its impact on daily function.  
 
Slightly different predictors emerged for caregiver burden, depression and anxiety, although 
the differences in the models should be interpreted with caution. Of the ALS symptoms, the 
severity of limb involvement was the best predictor of caregiver burden and depression, at 
least in the present sample of patients relatively early in their disease. Functional impairment 
may lead to increased physical dependence on the caregiver, imposing restrictions upon 
caregivers’ personal and social activities and needs (13, 33). With disease progression and 
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potential worsening of bulbar and respiratory impairments, these other symptoms may 
become more important for caregiver outcomes. Recent studies have emphasised the 
importance of the behavioural above the physical aspects of ALS on caregivers (14, 15). In 
contrast, the current results suggest that both patients’ physical and behavioural symptoms 
may act in concert in their impact on caregivers. The disparity in these findings might reflect 
differences in the patient samples in terms of the severity of ALS and behavioural symptoms. 
For example, perhaps responding to acute behavioural symptoms eventually dominates 
caregivers’ priorities even alongside the progression of the patient’s disability.    
 
As in previous studies, greater behavioural symptoms as measured by the FrSBe predicted 
poorer outcome in terms of burden, anxiety and marital satisfaction, even in spouses of 
patients in the first two years from diagnosis. This highlights the importance of detection of 
such problems early in the disease trajectory. The FrSBe Total score was a better predictor of 
caregiver outcome than the subscale scores, suggesting that global behavioural change may 
be a more useful indicator than individual behavioural symptoms for caregivers of non–
demented patients. This was true for the current sample despite more than half of the patients 
being endorsed for clinically relevant levels of apathy. Demographic characteristics did not 
emerge as independent predictors with the exception of patient age, with higher anxiety 
scores seen in the caregivers of younger patients. This may reflect concerns about the future 
in younger couples where the ALS may have greater economic and wider family impact.  
 
Caregivers’ levels of perceived marital satisfaction were significantly reduced compared to 
those reported for the period before their partners’ illness, replicating previous findings (34). 
However, the quality of the marital relationship prior to the onset of the ALS remained the 
most important determinant of current satisfaction. The significant association between 
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marital satisfaction and burden suggests that a poor pre–illness relationship increases the risk 
of greater burden in caregivers after the onset of ALS, or conversely, that a strong 
relationship is protective against the negative effects on caregiver outcome.  
 
Caregivers have reported that clinical services place disproportionate focus on the practical 
rather than emotional adjustments to the disease (35, 36). The current findings suggest that 
routine monitoring of the patient’s functional, cognitive and behavioural status may prepare 
the clinical team better to tailor their support for caregivers. Early interventions could include 
educating the caregiver about the possible interpersonal or behavioural changes that might 
accompany their partner’s disability, so that caregivers do not misinterpret their partner’s 
emerging disposition as resulting from inherent problems within their relationship (37).  
More formally, caregivers might benefit from group or individual psychosocial interventions, 
although, to date, none have been evaluated for potential efficacy in improving the wellbeing 
of ALS caregivers.  
 
This study is limited by its cross–sectional design; a longitudinal study of caregiver outcomes 
alongside patients’ declining functional status and behavioural change would further clarify 
the causal relationships and interactions between the measures as the ALS progresses. 
Although objective measures of patients’ neuropsychological performance were not 
predictive of caregiver outcomes here, there is merit in investigating whether changes in 
cognitive indices over time explain variability in caregiving outcomes at different stages of 
disease. As already mentioned, the relatively preserved cognitive status of the majority of 
patients in the sample may limit the inferences drawn regarding the influence of ALS-related 
cognitive impairment on caregivers’ wellbeing. Future research would benefit from including 
a more cognitively heterogeneous sample and/or comparisons between caregivers of “pure 
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ALS” and ALS-FTD.  The use of composite scores to measure patients’ cognitive functions 
may have underestimated or masked correlations for individual measures; however, these 
were necessary to allow parsimonious analyses for the small sample size. The HADS is not 
diagnostic of mood disorder and caregivers’ mean values for anxiety and depression did not 
suggest the presence of generally clinically significant dysthymia. Thus, the generalisability 
of these results to clinically depressed or anxious caregivers is restricted. The lack of 
objective FVC scores for some patients means that the study may underestimate the influence 
of subtle respiratory deficits (not noticeable to the patient or the clinical team) on patients’ 
cognitive performance and/or caregivers’ outcomes. The influence of recall bias on measures 
assessing retrospective outcomes cannot be excluded. Following ethical guidelines, the study 
could not record data from the nine spouses who declined to consent to the research and thus 
we cannot exclude the possibility of selection bias. Finally, this study emphasised caregivers’ 
experiences and precludes comment on the impact of ALS on patients and their spouses as a 
dyadic unit.  Nonetheless, the current findings implicate the roles of both patients’ functional 
impairment and behavioural dysfunction in caregivers’ responses to ALS. Our findings 
suggest, therefore, that clinical communication with ALS families should emphasise both the 
physical and psychological challenges presented by the cognitive–behavioural features of 
ALS.  
 
Acknowledgments 
We thank the people with ALS and their caregivers who participated in the research. We also 
thank members of the research support team who assisted with the participant recruitment for 
the study: Dr Rachel Burman, Catherine Knights, Andrew Dougherty, Dr Naomi Martin, 
Rachel Tuck, Jan Clarke, Christine Batts, Hazel Watts, Joanna Sasson, Helen Copesy, Trish 
Cutts.   
Page 15 of 32 
 
Funding 
This work was submitted in part fulfilment of a PhD project (for TJW) funded by the Medical 
Research Council, The National Institute of Health Research (NIHR) Dementias and 
Neurodegenerative Diseases Research Network and the Motor Neurone Disease Association. 
The work leading up to this publication was funded by the European Community’s Health 
Seventh Framework Programme (AAC & CES grant number 259867). AAC and CES are 
involved in two EU Joint Programmes–Neurodegenerative Disease Research (JPND) projects 
(STRENGTH and ALS–CarE). These projects are supported through the following funding 
organisations under the aegis of JPND –www.jpnd.eu: United Kingdom, Medical Research 
Council and Economic and Social Research Council. Some authors receive salary support 
from the NIHR Dementia Biomedical Research Unit (CES, AAC, RGB, LHG) and the NIHR 
Biomedical Research Centre for Mental Health (CES, AAC, RGB) at the South London and 
Maudsley NHS Foundation Trust and King’s College London. The views expressed are those 
of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. 
 
Declaration of conflicting interests 
None 
 
References 
1. Merrilees J, Klapper J, Murphy J, Lomen–Hoerth C & Miller BL. Cognitive and 
behavioral challenges in caring for patients with frontotemporal dementia and 
amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2010; 11: 298–302. 
2. Grossman AB, Woolley–Levine S, Bradley WG & Miller RG. Detecting neurobehavioral 
changes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2007; 8: 56–61. 
Page 16 of 32 
 
3. Gibbons Z, Richardson A, Neary D & Snowden JS. Behaviour in amyotrophic lateral 
sclerosis. Amyotroph Lateral Scler 2008; 9: 67–74. 
4. Witgert M, Salamone AR, Strutt AM, Jawaid A, Massman PJ, Bradshaw M, et al. 
Frontal–lobe mediated behavioral dysfunction in amyotrophic lateral sclerosis. Euro J 
Neurol 2010; 17: 103–110. 
5. Goldstein LH & Abrahams S. Changes in cognition and behaviour in amyotrophic lateral 
sclerosis: nature of impairment and implications for assessment. Lancet Neurol 2013; 12: 
368–380. 
6. Girardi A, MacPherson SE & Abrahams S. Deficits in emotional and social cognition in 
amyotrophic lateral sclerosis. Neuropsychology 2011; 25: 53–65. 
7. Lillo P, Savage S, Mioshi E, Kiernan MC & Hodges JR. Amyotrophic lateral sclerosis 
and frontotemporal dementia: A behavioural and cognitive continuum. Amyotroph  
Lateral Scler 2012; 13: 102–109. 
8. Gibbons Z, Snowden JS, Thompson JC, Happé F, Richardson A & Neary D. Inferring  
thought and action in motor neurone disease. Neuropsychologia 2007; 45: 1196–1207. 
9.  Staios M, Fisher F, Lindell AK, Ong B, Howe J & Reardon K. Exploring sarcasm  
       detection in amyotrophic lateral sclerosis using ecologically valid measures. Front Hum   
       Neurosci 2013; 7: 178. 
10.  Adelman EE, Albert SM, Rabkin JG, Del Bene ML, Tider T & O’Sullivan I. Disparities  
  in perceptions of distress and burden in ALS patients and family caregivers. Neurology 
  2004; 62: 1766–1770. 
11.  Gauthier A, Vignola A, Calvo A, Cavallo E, Moglia C, Sellitti L, et al. A longitudinal 
study on quality of life and depression in ALS patient–caregiver couples. Neurology 
2007; 68: 923–926. 
Page 17 of 32 
 
12.  Goldstein LH, Adamson M, Jeffrey L, Down K, Barby T, Wilson C, et al. The   
psychological impact of MND on patients and carers. J Neurol Sci 1998; 160: S114–
S121. 
13.  Goldstein LH, Atkins L, Landau S, Brown R & Leigh PN. Predictors of  
 psychological distress in carers of people with amyotrophic lateral sclerosis: a  
 longitudinal study. Psychol Med 2006; 36: 865–875. 
14.  Chio A, Vignola A, Mastro E, Guidici AD, Iazzolino B, Calvo A, et al. Neurobehavioral 
symptoms in ALS are negatively related to caregivers' burden and quality of life. Euro J 
Neurol  2010; 17: 1298–1303. 
15.  Lillo P, Mioshi E & Hodges JR. Caregiver burden in amyotrophic lateral sclerosis is     
 more dependent on patients' behavioral changes than physical disability: a comparative  
 study. BMC Neurol 2012; 12: 156. 
16.  Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness  
 scale. Sleep 1991; 14: 540–545. 
17.  Zigmond AS & Snaith RP. The Hospital Anxiety and Depression Scale. Acta      
 Psychiatr Scand 1983; 67: 361–370. 
18.  Zarit SH & Zarit JM. Instructions for the Burden Interview. Pennsylvania: Pennsylvania 
 State University, 1987. 
19.  Morris LW, Morris RG & Britton PG. The relationship between marital intimacy,    
        perceived strain and depression in spouse caregivers of dementia sufferers. Br J Med  
        Psychol 1988; 61: 231–236. 
20.  Cedarbaum JM, Stambler N, Malta E, Fuller C, Hilt D, Thurmond B, et al. The 
ALSFRS–R: a revised ALS functional rating scale that incorporates assessments of 
respiratory function.  J Neurol Sci 1999; 169:13–21. 
Page 18 of 32 
 
21. Gibbons C, Mills, R, Thornton, E, Ealing J, Mitchell JD, Shaw PJ et al. Rasch analysis of 
the hospital anxiety and depression scale (hads) for use in motor neurone disease. Health 
Qual Life Outcomes 2011; 9: 1-8.  
22. Abrahams, S, Leigh, PN, Harvey, A, Vythelingum, GN, Grise, D & Goldstein, LH. 
Verbal fluency and executive dysfunction in amyotrophic lateral sclerosis (ALS). 
Neuropsychologia 2000; 38: 734-747.  
23. Delis D, Kaplan E, Krammer J. Delis- Kaplan Executive Function System. San Anotonio, 
USA: Psychological Corporation, 2001.  
24. Burgess, PW & Shallice, T. The Hayling and Brixton Tests. Bury St Edmonds, UK: 
Thames Valley Company, 1997. 
25. McDonald, S, Flanagan, S & Rollins, JB. The Awareness of Social Inference Test 
(TASIT). St Edmonds, UK: Thames Valley Test Company, 2002. 
26. Happé, F, Brownell, H, & Winner, E. Acquired `theory of mind' impairments following 
stroke. Cognition 1999; 70: 211-24. 
27. Baron-Cohen, S, Wheelwright, S, Hill, J, Raste, Y, & Plumb, I. The “Reading the Mind 
in the Eyes” Test Revised Version: A Study with Normal Adults, and Adults with 
Asperger Syndrome or High-functioning Autism. J Child Psychol Psychiatry 2001; 42: 
241-251. 
28. Grace J & Malloy P. The Frontal Systems Behavioural Scale (FrSBe). Florida:  
  Psychological Assessment Resources Inc, 2001.  
29.  Newsom–Davis IC, Abrahams S, Goldstein LH & Leigh PN. The emotional lability  
 questionnaire: a new measure of emotional lability in amyotrophic lateral sclerosis.  
 J Neurol Sci 1999; 169: 22–25. 
Page 19 of 32 
 
30. Strong, MJ, Grace, GM, Freedman, M, Lomen-Hoerth, C, Woolley, SC, Goldstein, LH, 
et al. Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural 
syndromes in amyotrophic lateral sclerosis. Amyotroph Lateral Scler 2009; 10: 131-146.  
31. Miller LA, Mioshi E, Savage S, Lah S, Hodges JR & Piguet O. Identifying cognitive and  
 demographic variables that contribute to carer burden in dementia. Dement Geriatr Cogn 
Disord 2013; 36: 43–49. 
32.  Dean K & Wilcock G. Living with mild cognitive impairment: the patient's and carer's  
 experience. Int Psychogeriatr 2012; 24: 871–881.  
33.  Hecht MJ, Graesel E, Tigges S, Hillemacher T, Winterholler M, Hilz MJ, et al. Burden 
of care in amyotrophic lateral sclerosis. Palliat Med 2003; 17: 327–333. 
34.  Atkins L, Brown RG, Leigh PN, & Goldstein LH. Marital relationships in amyotrophic 
lateral sclerosis. Amyotroph Lateral Scler 2010; 11: 344–350. 
35. Brown, J. User, carer and professional experiences of care in motor neurone disease. 
Primary health care research and development 2003; 4: 207-218. 
36. Oyebode, J, Smith, H & Morrison, K. The personal experience of partners of individuals 
with motor neuron disease. Amyotroph Lateral Scler Frontotemporal Degener 2013; 14: 
39-43. 
37. Abrahams, S. Social cognition in amyotrophic lateral sclerosis. Neurodegener Dis Manag 
2011; 1: 397-405.  
 
 
 
 
 
 
 
 
 
 
 
 
Page 20 of 32 
 
Table 1 Descriptions of Executive Function and Social Cognition Tasks 
 
Task                       Description                                                        Scoring 
 
 
The verbal 
fluency index  
(22) 
 
Participants write down/say as many 
words as possible in a given time limit 
and under conditions in which the 
response is specified by a particular 
restriction, such as a letter. In this study 
participants had to produce as many 
words beginning with S as they could in 
five minutes and as many 4–letter words 
beginning with C in four minutes. In a 
subsequent control condition the 
participant copies/reads out these words 
as quickly as they can. 
 
An index is calculated by 
subtracting the time taken to 
copy/read aloud the words 
from the duration of the word 
generation condition and 
dividing this by the total 
number of words generated. 
This index represents the 
average time taken to 
generate each word; higher 
scores indicating longer 
thinking times and greater 
executive impairment. 
 
 
The Card 
Sorting task 
from the 
Delis–Kaplan 
Executive 
Function Scale  
(23) 
Participants sort cards into mutually 
exclusive categories based on the verbal 
or visual information of the cards with 
the goal of making as many sorts as 
possible. Participants are required to 
describe the conceptual relationships 
between cards within each created 
category.  
 
The maximum possible 
scores (32 for number of sorts 
made; 64 for description 
scores) minus the 
participant’s score served as a 
measure of ‘errors’ on these 
conditions; the higher these 
scores, the worse the 
performance on these 
conditions.  
 
The Brixton 
Spatial 
Anticipation 
test (24) 
Participants are presented with series of 
arrays containing 10 circles. Each array 
contains one coloured circle, the position 
of which varies from one array to the 
next according to implicit rules (which 
change abruptly). Participants indicate 
the likely position of the coloured circle 
in the following array. 
 
The outcome measure was 
the total number of errors, 
with higher scores indicating 
worse performance 
(maximum possible errors 
were 56) 
Three subtests 
of The 
Awareness of 
Social 
Inference Test 
(TASIT) (25) 
These tasks use enacted scenes of 
everyday social interaction: Emotional 
Evaluation (EET, dynamic videos of 
basic emotion expression); Social 
Inference–minimal (SIM–M, dynamic 
videos portraying sincere and sarcastic 
social exchanges); Social Inference–
enriched (SI–E, dynamic videos 
portraying sincere, sarcastic and 
deceptive social exchanges) 
The maximum possible 
scores (EET: 28; SI–M: 60; 
SI–E: 64) minus the 
participant’s scores on each 
subtask served as a measure 
of ‘errors’; the higher the 
scores, the worse the 
performance. 
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Three subtests 
of the Happé 
Cartoon and 
Scenarios Task 
(26) 
These tasks use humorous cartoons and 
vignettes depicting characters in social 
situations involving deception, belief and 
intention. In the experimental conditions, 
the targeted inference related to the 
mental states of these characters. In 
control conditions, the targeted inference 
related to physical causation or logical 
sequence.  
The maximum possible 
scores (cartoon task 1: 32; 
cartoon task 2: 30; vignettes: 
32) minus the participant’s 
score served as a measure of 
‘errors’; the higher these 
scores the worse the 
performances.  
 
The Reading in 
Mind in the 
Eyes (RME) 
task (27) 
Participants are required to attribute 
complex mental or emotional states to 
facial images depicting only the eye 
region. 
The maximum score (36) 
minus the participant’s score 
served as a measure of 
‘errors’; the higher the score 
the worse the performance.   
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Table 2 Patient demographics and disease information 
Min, minimum; Max, maximum; ALSFRS–R, Amyotrophic Lateral Sclerosis Functional 
Rating Scale: bulbar = items 1–3; Limb = items 4–9; respiratory = items 10–12, lower scores 
indicate greater functional impairment.  
 
 
 
 
 
 
 
 
 
 
 
                                                                                                Mean      SD           Min - Max 
Age 
Education (years ) 
Months since symptom onset 
Months since diagnosis 
Age at symptom onset 
ALFSFRS–R total severity score (max 48) 
ALSFRS–R bulbar severity score (max 12) 
ALSFRS–R Limb severity score (max 12) 
ALSFRS–R Respiratory severity score (max 12) 
Epworth Sleepiness Scale Score (max 24)  
60.9        8.4           32.0 - 80.0 
14.2        3.6           10.0 - 24.0 
30.4        14.3         10.0 - 75.0 
14.8        12.2         3.0 - 51.0 
58.6        8.5           34.0 - 72.0 
34.1        8.2            9.0 - 48.0 
9.3          3.0           1.0 - 12.0 
14.0        6.0           3.0 - 24.0 
10.8        2.0           2.0 - 12.0  
3.3  
 
        2.9
      
       0.0 - 10.0 
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 Table 3  Mood, cognitive performance and behaviour of ALS participants 
Measure                                            Mean    SD           Min-Max    N    Cut-off
  
 No. (%)
a
           
                                                                                                                                     
 
HADS-R  Depression score   
HADS-R  Anxiety score  
Executive Function Composite  
Social Cognition Composite  
VFI – S words  
VFI – C words 
 
DKEFS Card Sorting  
DKEFS Card Sorting Description   
Brixton errors  
 
TASIT Emotion Evaluation Test  
 
TASIT Social Inference Minimal 
 
TASIT Social Inference Enriched 
 
Happé Cartoons task 1  
 
Happé Cartoons task 2   
 
Happé Scenarios  
 
RME  
 
FrSBe Total  
FrSBe Apathy  
FrSBe Disinhibition 
FrSBe Executive Dysfunction 
ELQ Total
 
 
2.5       2.1            0.0-9.0       35     8         1 (2.9) 
   
  4.3       3.7            0.0-18.0     35     9         5 (14.3) 
  0.5       0.4           -0.5-3.3      35     1.6       5 (14.3) 
  0.4       0.8           -0.9-2.9      35     1.7       4 (11.4) 
  5.3       3.3            0.9-14.4     35    8.6        6 (17.1)           
 16.2      12.0          0.04-39.3   35     20.7     3 (8.6) 
6.3       2.1            2-10           33     12        2 (6.1) 
28.5     11.3          8-54           33     47        3 (9.1) 
18.1     5.4            7-30           35     29.5     2 (5.7) 
6.1       2.8            2-13           35     11        3 (8.6) 
11.1     7.6            0-33           35     17        7 (20) 
12.3     6.2            4-29           35     25        1 (2.9) 
11.9     5.7            1-24           29     20.6     3 (10.3) 
12.2     4.7            2-21           29     18.6     0 (0) 
9.2       4.1            1-17           25     19.1     0 (0) 
11.9     4.8            4-21           34     17        4 (11.8) 
  63.7     12.8          42-107       33     65       11 (33.3)  
  69.2     13.6          46-94         33     65       19 (57.6) 
  55.0     11.8          39-88         33     65        5 (15.2) 
  60.0     13.3          41-102       33     65       10 (30.3) 
  5.0
b
      0.0-15.5
c 
  0.0-43.0    34      21       6 (17.6) 
Higher scores indicate worse mood, cognitive performance and greater behavioural 
impairment and greater emotional lability. 
a
Number and percentage of patients meeting cut-
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off criteria for ‘caseness’ (HADS-R); performance at or below 5th percentile of controls 
(composites, cognitive tests scores and ELQ) and clinically relevant behaviour (FrSBe); 
b
Median; 
c
IQR.  
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Table 4 Caregivers’ self–ratings for outcomes 
 
Higher scores indicate worse symptoms except for the MIS measure in which higher scores 
indicate greater marital satisfaction. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Caregiver self–report 
measures 
 Scores     Mean     SD              N 
  
The Hospital Anxiety and 
Depression Scale 
(HADS)(17) 
 
The Zarit Burden Interview 
(ZBI)(18) 
 
The Marital Intimacy Scale 
(MIS)(19) 
 HADS A 
 HADS D 
 
 
 ZBI Total 
 
 
 MIS pre–ALS 
 MIS current 
9.2          4.6              35 
5.7          4.0              35 
 
 
29.4        14.1            34 
 
 
76.1        5.4              32  
70.2        18.4            32   
Page 26 of 32 
 
Table 5 Predictors of caregivers’ outcomes 
Table displays output for forward regression analyses except for Marital Intimacy which is a 
hierarchical regression analysis. Adj., Adjusted; β, standardised beta; ALSFRS–R Limb, 
Amyotrophic Lateral Sclerosis Functional Rating Scale–Revised Limb subscale; FrSBe Tot., 
Frontal Systems Behaviour Scale Total T score; MIS pre–illness, Marital Intimacy Scale 
score rated for period two years prior to ALS onset.    
 
 Model 1 
 
Model 2 
Outcome 
Predictor 
R
2
 Adj. 
R
2
 
β p  R2 Adj. 
R
2
 
β p 
Depression          
 
ALSFRS–R 
Limb 
 
 
0.21 
 
0.18 
 
-0.45 
 
<0.01 
     
Anxiety          
 
FrSBe Tot. 
 
 
Patients’ 
age (years) 
 
 
0.16 
 
0.13 
 
0.40 
 
0.02 
  
0.27 
 
 
 
 
 
0.22 
 
0.35 
 
 
-0.34 
 
0.04 
 
 
0.04 
Burden          
 
FrSBe Tot. 
 
 
ALSFRS–R 
Limb 
 
 
0.60 
 
0.59 
 
0.78 
 
<0.01 
  
0.85 
 
0.84 
 
0.69 
 
 
-0.51 
 
<0.01 
 
 
<0.01 
Marital 
Intimacy 
 
MIS pre–
illness 
 
FrSBe Tot. 
 
 
 
 
0.63 
 
 
 
0.62 
 
 
 
0.80 
 
 
 
<0.01 
  
 
 
0.80 
 
 
 
0.78 
 
 
 
0.68 
 
 
-0.42 
 
 
 
<0.01 
 
 
<0.01 
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Table 1 Descriptions of Executive Function and Social Cognition Tasks 
 
 
 
Table 2 Patient demographics and disease information 
 
Min, minimum; Max, maximum; ALSFRS–R, Amyotrophic Lateral Sclerosis Functional 
Rating Scale: bulbar = items 1–3; Limb = items 4–9; respiratory = items 10–12, lower scores 
indicate greater functional impairment.  
 
 
Table 3  Mood, cognitive performance and behaviour of ALS participants 
 
Higher scores indicate worse mood, cognitive performance and greater behavioural 
impairment. 
a 
Number and percentage of patients meeting cut-off criteria for ‘caseness’ 
(HADS-R), performance at or below 5
th
 percentile of controls (composites and cognitive tests 
scores) and clinically relevant behaviour (FrSBe); 
b
No cut-off score has been established for 
ELQ;
 c
Median; 
d
IQR. 
 
 
Table 4 Caregivers’ self–ratings for outcomes  
 
Higher scores indicate worse symptoms except for the MIS measure in which higher scores 
indicate greater marital satisfaction. 
 
 
Table 5 Predictors of caregivers’ outcomes 
Table displays output for forward regression analyses except for Marital Intimacy which is a 
hierarchical regression analysis. Adj., Adjusted; β, standardised beta; ALSFRS–R Limb, 
Amyotrophic Lateral Sclerosis Functional Rating Scale–Revised Limb subscale; FrSBe Tot., 
Frontal Systems Behaviour Scale Total T score; MIS pre–illness, Marital Intimacy Scale 
score rated for period two years prior to ALS onset.    
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Supplementary Appendix  
 
 
Table S1 Information regarding larger parallel study investigating cognitive-behavioural changes in 
ALS 
 
Study Aims i)  to delineate the nature and extent of changes in social   
     cognition in ALS and  
ii) to determine the relationship between such changes and 
interindividual differences in mood, behaviour, personality, 
empathy and ALS–related executive dysfunction.  
 
Sample 55 ALS patients and 49 Healthy Controls 
 
Control sample demographics  
(n=49) 
 
Age 
 
Education (years) 
 
HADS-R Anxietya  
 
HADS-R Depressiona 
 
Gender Female  
Mean        SD              Range        N        % 
 
 
60.0          9.7                36-73 
 
14.5          2.7                10-23 
 
4.4            3.0                 0-12 
 
2.0            2.0                 0-7 
 
                                                       15       30.6 
 
aHospital Anxiety and Depression Scale-Revised version (Gibbons et al, 2011) 
 
 
Gibbons, C., Mills, R., Thornton, E., Ealing, J., Mitchell, J., Shaw, P., Talbot, K., Tennant, A., & Young, C. A. 
(2011). Rasch analysis of the hospital anxiety and depression scale (hads) for use in motor neurone disease. 
Health and Quality of Life Outcomes, 9(1), 1-8. 
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Table S2. Correlations between caregiver outcome variables 
  HADS, Hospital Anxiety and Depression Scale scores (n = 35): A (anxiety subscale), D   
  (depression subscale); ZBI, Zarit Burden Interview (n = 34); MIS, Marital Intimacy Scale 
 (n = 32).  
 
 
 
 
 
 
 
 
 
 
R 
(p–values) 
HADS A 
HADS A 
 
1.00 HADS D 
HADS D 0.42 
(0.01) 
 
1.00 
 
ZBI 
ZBI 
 
0.37 
(0.03) 
 
0.57 
(<0.001) 
1.00 MIS 
Current 
MIS 
Current 
0.10 
(0.63) 
 
-0.06 
(0.77) 
-0.45 
(0.009) 
1.00 
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Table S3 Demographic, disease and cognitive profile of 9 ALS patients who spouse declined participation  
Measure                                                         Mean    SD           Min-Max    N     Cut-off
  
 No. (%)
a
                                                                                                                                          
Age 
Age at symptom onset 
Education (years) 
Months since symptom onset 
Months since diagnosis 
ALSFRS-R Total (max 48) 
ALSFRS-R Bulbar (max 12) 
ALSFRS-R Limb (max 12) 
ALSFRS-R Respiratory (max 12) 
Epworth Scale (max 24) 
HADS-R  Depression score   
HADS-R  Anxiety score  
Executive Function Composite  
Social Cognition Composite 
VFI – S words                                                           
VFI – C words                                 
 
DKEFS Card Sorting  
DKEFS Card Sorting Description   
Brixton errors  
 
TASIT Emotion Evaluation Test  
 
TASIT Social Inference Minimal 
 
TASIT Social Inference Enriched 
 
Happé Cartoons task 1  
 
Happé Cartoons task 2                                    
 
Happé Scenarios  
 
RME  
57.7     8.2          43-65           9      
   
  54.8     8.2          40-63           9      
  14.4     3.6           9-19            9      
  35.2     26.9         13-82          9      
  16.3     23.9          3-76           9      
  34.2     8.2            22-45         9     
 9.8      1.6             8-12          9     
 13.3    8.4             0-23          9     
 11.1    0.8             10-12        9   
  4.3     3.3             0-10          9        
  2.2     1.9             0-6            9        8        0 (0) 
  5.4     2.9             2-10          9        9        2 (22.2) 
  0.2     0.8            -0.4-2.1      9       1.6      1 (11.1) 
    0.7     0.5            -0.8-0.9      9       1.7      0 (0) 
4.7     3.1            1.5-10.8     9       8.6      2 (22.2) 
    12.7   10.2          5.6-39.3     9       20.7    0 (0) 
    5.6     1.7            3-8             9       12       0 (0) 
    21.2   5.9            12-32         9        47      0 (0) 
    18.3   6.0            9-29           9        29.5   0 (0)   
    5.0     1.4            3-7             9        11      0 (0) 
    8.8     4.4            4-17           9        17      1 (11.1)     
    12.0   5.6            4-22           9        25      0 (0) 
    10.7   1.7            8-13           7        20.6   0 (0) 
    10.0   4.9            2-18           7        18.6   0 (0) 
    9.7     5.2            6-20           6        19.1   1 (16.7) 
    9.4     3.2            6-15           9        17      0 (0) 
 
Higher scores indicate worse mood, cognitive performance and greater behavioural impairment. 
a
Number and percentage of patients meeting cut-off criteria for ‘caseness’ (HADS-R), performance at or 
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below 5
th
 percentile of controls (composites and cognitive tests scores).  
 
  
Page 32 of 32 
 
Figure 1 Number of impairments on tests of executive function, social cognition and FrSBe domains 
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